Anthony Montanaro

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 216 citations · Full text

Asthma, Pulmonary Care, Phase 2B +6

Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus

Jeffrey D. Hosenpud, Anthony Montanaro, Mark V. Hart et al. · The American Journal of Medicine · 1984 · 100 citations

Rheumatology, Heart Failure, Autoimmune Disease +9

Formaldehyde: an analysis of its respiratory, cutaneous, and immunologic effects.

Bardana Ej, Anthony Montanaro · PubMed · 1991 · 85 citations

Asthma, Immunotoxicology, Air Quality +18

Results of the First U.S. Double-Blind, Placebo-Controlled, Multicenter Clinical Study in Asthma with Pranlukast, a Novel Leukotriene Receptor Antagonist

Jay Grossman, Isidore Faiferman, Jeffrey W. Dubb et al. · Journal of Asthma · 1997 · 81 citations

Asthma, Inflammation, Multicenter Clinical Study +13

Sporotrichosis in the acquired immunodeficiency syndrome

James C. Shaw, Wendy Levinson, Anthony Montanaro · Journal of the American Academy of Dermatology · 1989 · 74 citations

Primary Immunodeficiency, Autoimmune Disease, Medicine +9